Glaucoma therapy and ocular surface disease: Current literature and recommendations

Zane Anwar; Sarah R. Wellik; Anat Galora

doi:10.1097/ICU.0b013e32835c8aba

Glaucoma therapy and ocular surface disease: Current literature and recommendations

Zane Anwar, Sarah R. Wellik, Anat Galora

Ophthalmology

Research output: Contribution to journal › Review article

54 Scopus citations

Abstract

BAK-free and preservative-free therapies are becoming available but are not always a feasible alternative. It is important to recognize different clinical manifestations of allergy and chronic inflammation and to discuss options for patients experiencing OSD.

Original language	English (US)
Pages (from-to)	136-143
Number of pages	8
Journal	Current opinion in ophthalmology
Volume	24
Issue number	2
DOIs	https://doi.org/10.1097/ICU.0b013e32835c8aba
State	Published - Mar 1 2013

Keywords

Benzalkonium Chloride
Glaucoma
Ocular Surface Disease
Preservatives
Recommendations

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1097/ICU.0b013e32835c8aba

Fingerprint Dive into the research topics of 'Glaucoma therapy and ocular surface disease: Current literature and recommendations'. Together they form a unique fingerprint.

Cite this

Anwar, Z., Wellik, S. R., & Galora, A. (2013). Glaucoma therapy and ocular surface disease: Current literature and recommendations. Current opinion in ophthalmology, 24(2), 136-143. https://doi.org/10.1097/ICU.0b013e32835c8aba

@article{a25345293b3447928b8e682a0a7fbe35,

title = "Glaucoma therapy and ocular surface disease: Current literature and recommendations",

abstract = "BAK-free and preservative-free therapies are becoming available but are not always a feasible alternative. It is important to recognize different clinical manifestations of allergy and chronic inflammation and to discuss options for patients experiencing OSD.",

keywords = "Benzalkonium Chloride, Glaucoma, Ocular Surface Disease, Preservatives, Recommendations",

author = "Zane Anwar and Wellik, {Sarah R.} and Anat Galora",

year = "2013",

month = mar,

day = "1",

doi = "10.1097/ICU.0b013e32835c8aba",

language = "English (US)",

volume = "24",

pages = "136--143",

journal = "Current Opinion in Ophthalmology",

issn = "1040-8738",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Glaucoma therapy and ocular surface disease

T2 - Current literature and recommendations

AU - Anwar, Zane

AU - Wellik, Sarah R.

AU - Galora, Anat

PY - 2013/3/1

Y1 - 2013/3/1

N2 - BAK-free and preservative-free therapies are becoming available but are not always a feasible alternative. It is important to recognize different clinical manifestations of allergy and chronic inflammation and to discuss options for patients experiencing OSD.

AB - BAK-free and preservative-free therapies are becoming available but are not always a feasible alternative. It is important to recognize different clinical manifestations of allergy and chronic inflammation and to discuss options for patients experiencing OSD.

KW - Benzalkonium Chloride

KW - Glaucoma

KW - Ocular Surface Disease

KW - Preservatives

KW - Recommendations

UR - http://www.scopus.com/inward/record.url?scp=84876210030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876210030&partnerID=8YFLogxK

U2 - 10.1097/ICU.0b013e32835c8aba

DO - 10.1097/ICU.0b013e32835c8aba

M3 - Review article

C2 - 23542350

AN - SCOPUS:84876210030

VL - 24

SP - 136

EP - 143

JO - Current Opinion in Ophthalmology

JF - Current Opinion in Ophthalmology

SN - 1040-8738

IS - 2

ER -